Approvals/TGA/SPIKEVAX (elasomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial - multidose

Approved

STANDARD

SPIKEVAX (elasomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial - multidose

Moderna Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 846668dd1db024f6
Product Name: SPIKEVAX (elasomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial - multidose
Artg Id: 388244
Artg Name: SPIKEVAX (elasomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial - multidose
Sponsor: Moderna Australia Pty Ltd
Company Detail Path: /organization/moderna-australia-pty-ltd
Artg Date: 2022-07-19
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/ee0dbf7623ce1e7da1866b2a6fc11e63.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/214816f7d8dd1fc6ebff0f82f6d4c055.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

846668dd1db024f6

Type

Standard